cephalosporin c has been researched along with piperidines in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Moll, F; Wieland, HJ | 1 |
| Nishiura, T; Tamura, M | 1 |
| Eto, K; Hayashida, K; Shigematsu, S | 1 |
| Close, R; Genicot, B; Lambert, P; Lekeux, P; Lindsey, JK; Mouligneau, F | 1 |
| Wei, DZ; Zhang, YW | 1 |
| Livermore, DM; Mushtaq, S; Vickers, A; Warner, M; Woodford, N | 1 |
| Castanheira, M; Flamm, RK; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Chavan, R; Patel, M; Patil, K; Tambe, H; Yeole, R; Zope, V | 1 |
| Abdelraouf, K; Kidd, JM; Nicolau, DP | 1 |
| Garello, P; Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
| Abdelraouf, K; Lasko, MJ; Nicolau, DP | 1 |
| Barceló, I; Bhagwat, S; Cabot, G; Cortés-Lara, S; Joshi, P; Moya, B; Oliver, A; Palwe, S; Patel, M; Periasamy, H; Sánchez-Diener, I; Takalkar, S; Zamorano, L | 1 |
| Chaudhry, A; Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
| Carvalhaes, CG; Castanheria, M; Duncan, LR; Mendes, RE; Sader, HS | 1 |
| Alonso-García, I; Arca-Suárez, J; Beceiro, A; Bou, G; Cabot, G; Fraile-Ribot, PA; Galán-Sánchez, F; Guijarro-Sánchez, P; Lasarte-Monterrubio, C; Oliver, A; Rumbo-Feal, S; Vázquez-Ucha, JC | 1 |
2 trial(s) available for cephalosporin c and piperidines
| Article | Year |
|---|---|
[A double blind study of rifampicin].
Topics: Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Piperidines; Rifampin; Urinary Tract Infections | 1970 |
[Clinical evaluation of rifampicin in urinary tract infections by double blind method].
Topics: Adolescent; Adult; Aged; Bacteria; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Piperidines; Rifampin; Urinary Tract Infections | 1970 |
13 other study(ies) available for cephalosporin c and piperidines
| Article | Year |
|---|---|
[Cepham analogs and cepham isomers (author's transl)].
Topics: Bridged-Ring Compounds; Cephalosporins; Cyclization; Isomerism; Magnetic Resonance Spectroscopy; Piperidines | 1975 |
Induction of serotonin-S2 receptor blockade during early or late stage of acute respiratory distress syndrome in double-muscled calves: a comparative study.
Topics: Animals; Cattle; Cattle Diseases; Cephalosporins; Drug Therapy, Combination; Piperidines; Respiration; Respiratory Distress Syndrome; Serotonin Antagonists | 1993 |
Enzymatic preparation of cefaclor with immobilized penicillin acylase.
Topics: Alcaligenes; Catalysis; Cephalosporins; Enzymes, Immobilized; Penicillins; Piperidines | 2008 |
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Citrobacter; Cyclooctanes; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Piperidines | 2017 |
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Simultaneous determination of zidebactam and cefepime in dog plasma by LC-MS/MS and its application to pre-clinical pharmacokinetic study.
Topics: Animals; Azabicyclo Compounds; Cefepime; Cephalosporins; Chromatography, Liquid; Cyclooctanes; Dogs; Drug Stability; Linear Models; Male; Piperidines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cefepime; Cephalosporins; Cyclooctanes; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Lung; Mice; Microbial Sensitivity Tests; Neutropenia; Piperidines; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms | 2020 |
Activity of cefepime/zidebactam (WCK 5222) against 'problem' antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Gram-Negative Bacteria; Laboratories; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa | 2021 |
Comparative in vivo activity of human-simulated plasma and epithelial lining fluid exposures of WCK 5222 (cefepime/zidebactam) against KPC- and OXA-48-like-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Humans; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Piperidines; Pneumonia | 2021 |
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Mice; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa | 2021 |
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer effect, as tested by BSAC agar dilution.
Topics: Agar; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Ertapenem; Microbial Sensitivity Tests; Piperidines | 2022 |
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19).
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cyclooctanes; Enterobacteriaceae; Gram-Negative Bacteria; Hydrazines; Lactams; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Tazobactam | 2022 |
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Borinic Acids; Carboxylic Acids; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Cyclooctanes; Humans; Imipenem; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |